These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4900161

  • 1. [Clinical significance of L-asparaginase].
    Benkö S.
    Orv Hetil; 1969 Aug 31; 110(35):2019-23. PubMed ID: 4900161
    [No Abstract] [Full Text] [Related]

  • 2. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
    Charles LM, Bono VH.
    Cancer Treat Rep; 1981 Aug 31; 65 Suppl 4():39-46. PubMed ID: 7049380
    [No Abstract] [Full Text] [Related]

  • 3. [Results of a cooperative clinical study of Soviet L-asparaginase from E. coli].
    Kondrat'eva NA, Lorie IuI, Kruglova GV, Vorob'ev AI, Brilliant MD.
    Probl Gematol Pereliv Krovi; 1980 Jul 31; 25(7):3-9. PubMed ID: 6995975
    [No Abstract] [Full Text] [Related]

  • 4. [Asparaginase].
    Boiron M, Jacquillat C, Weil M, Tanzer J, Bernard J.
    Presse Med (1893); 1968 Nov 16; 76(44):2099-101. PubMed ID: 4882819
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative evaluation of the clinical effectiveness of 3 preparations of E. coli L-asparaginase].
    Kondrat'eva NA.
    Antibiotiki; 1984 Jul 16; 29(7):527-31. PubMed ID: 6385831
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [First results of the treatment of acute leukemia with L-asparaginase].
    Marmont A, Damasio E, Bordo D, Fazio F, Gori E, Rossi F.
    Haematologica; 1970 Jul 16; 55(9):593-6. PubMed ID: 4996527
    [No Abstract] [Full Text] [Related]

  • 9. L-Asparaginase: discovery and development as a tumor-inhibitory agent.
    Broome JD.
    Cancer Treat Rep; 1981 Jul 16; 65 Suppl 4():111-4. PubMed ID: 7049374
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of lymphoma 6C3HED by L-asparaginase from Serratia marcescens.
    Boyd JW, Phillips AW.
    J Natl Cancer Inst; 1971 Jun 16; 46(6):1271-6. PubMed ID: 4932428
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cytostatic effect of L-asparaginase].
    Rakowska-Wódz A, Szyszka K, Abucewicz A.
    Wiad Lek; 1970 Jan 15; 23(2):117-20. PubMed ID: 4985374
    [No Abstract] [Full Text] [Related]

  • 16. [Therapy of leukemia in USA. 2. L asparaginase in leukemia].
    Böttiger LE.
    Lakartidningen; 1969 Jan 29; 66(5):455-60. PubMed ID: 5254602
    [No Abstract] [Full Text] [Related]

  • 17. The effects of immunization to L-asparaginase on antitumor and enzymatic activity.
    Goldberg AI, Cooney DA, Glynn JP, Homan ER, Gaston MR, Milman HA.
    Cancer Res; 1973 Feb 29; 33(2):256-61. PubMed ID: 4569788
    [No Abstract] [Full Text] [Related]

  • 18. Enhancement of asparaginase-induced regression of the 6C3HED lymphosarcoma by protein-free diet.
    Ryan WL, Sornson HC.
    Cancer Res; 1973 May 29; 33(5):1062-4. PubMed ID: 4574058
    [No Abstract] [Full Text] [Related]

  • 19. [Immobilized asparaginase and its use in medicine].
    Kozlov EA, Petriĭ OP.
    Vopr Med Khim; 1978 May 29; 24(6):723-33. PubMed ID: 32657
    [No Abstract] [Full Text] [Related]

  • 20. In vitro test for sensitivity of leukemic cells to L-asparaginase.
    Schrek R, Dolowy WC.
    Cancer Res; 1971 May 29; 31(5):523-6. PubMed ID: 4932205
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.